Valerio, M. S., Edwards, J. B., Dolan, C. P., Motherwell, J. M., Potter, B. K., Dearth, C. L., & Goldman, S. M. (2023). Effect of targeted cytokine inhibition on progression of post-traumatic osteoarthritis following intra-articular fracture. Int J Mol Sci, 24(17). https://doi.org/10.3390/ijms241713606
Intra-articular fractures can lead to prolonged inflammation and a 20-fold increase in the risk of developing post-traumatic osteoarthritis. This study tested the effects of a tumor necrosis factor – alpha inhibitor and an interleukin-1 receptor antagonist on IAF healing in rats. Because of significant negative side-effects in the initial phases of the study, INX was determined to be unsuitable for IAF treatment. While the IL-1 receptor antagonist ANR reduced pro-inflammatory markers, osteochondral degradation, and improved bones density, there was no significant improvement in macroscopic pathology using OARSI scoring, and glycosaminoglycan content decreased. These findings indicate that targeted inhibition of cytokines, particularly IL-1 may reduce the inflammatory response triggered by IAF; however, the extent of damage in this IAF model might have overwhelmed some of the beneficial effects of inhibiting IL-1.